Department of Ophthalmology, Flinders University, Flinders Medical Centre, Adelaide, South Australia, Australia.
Department of Ophthalmology, University of Adelaide, Royal Adelaide Hospital, Adelaide, South Australia, Australia.
Clin Exp Ophthalmol. 2018 May;46(4):417-423. doi: 10.1111/ceo.13083. Epub 2017 Nov 16.
Visual outcomes following diabetic vitrectomy have not previously been studied in an Australian population.
This analysis aimed to determine the rate of, and factors associated with visual success following diabetic vitrectomy performed for Indigenous and non-Indigenous Australians, and investigate factors predisposing to early progression to diabetic retinopathy (DR) requiring vitrectomy.
Retrospective, population-based audit.
All patients undergoing vitrectomy for the complications of DR in South Australia (SA) and the Northern Territory (NT) between 2007 and 2011.
Medical records were audited and data collected, including demographics, diabetic history, past treatment for DR, indication for vitrectomy and visual acuity pre and postoperatively.
Visual success (gain of ≥15 ETDRS letters) at 6 and 12 months, postoperatively.
A total of 495 diabetic vitrectomies, for 404 eyes of 335 patients were performed in SA and NT between 2007 and 2011. 77 (23%) patients requiring diabetic vitrectomy were Indigenous Australians. 87% of patients undergoing diabetic vitrectomy had stable or improved vision at 1 year, postoperatively. There was no significant difference between indigenous and non-indigenous eyes achieving visual success (P = 0.929). Timely preoperative laser treatment (P = 0.03) and preoperative visual acuity (P = 0.01) were the predominant factors associated with visual success.
Indigenous patients are just as likely to have improved vision following diabetic vitrectomy as non-Indigenous Australians. However, the small subset of indigenous patients with blind eyes prior to vitrectomy are significantly less likely to improve from surgery. The underlying factors associated with poor outcomes in this group requires further exploration.
此前,尚未在澳大利亚人群中研究过糖尿病玻璃体切除术的视觉结果。
本分析旨在确定澳大利亚原住民和非原住民接受糖尿病玻璃体切除术治疗后的视觉成功率及其相关因素,并研究导致糖尿病性视网膜病变(DR)早期进展至需要玻璃体切除术的因素。
回顾性、基于人群的审计。
2007 年至 2011 年期间,在南澳大利亚州(SA)和北领地(NT)因 DR 并发症接受玻璃体切除术的所有患者。
审核病历并收集数据,包括人口统计学资料、糖尿病史、DR 既往治疗、玻璃体切除术的适应证以及术前和术后视力。
术后 6 个月和 12 个月的视觉成功率(增加≥15 ETDRS 字母)。
2007 年至 2011 年期间,在 SA 和 NT 共进行了 495 例糖尿病玻璃体切除术,共 404 只眼,335 例患者。需要糖尿病玻璃体切除术的 77 例(23%)患者为原住民澳大利亚人。87%的糖尿病玻璃体切除术后患者在 1 年时视力稳定或改善,术后。在实现视觉成功方面,原住民和非原住民眼睛之间没有显著差异(P=0.929)。及时的术前激光治疗(P=0.03)和术前视力(P=0.01)是与视觉成功相关的主要因素。
与非原住民澳大利亚人相比,原住民患者在接受糖尿病玻璃体切除术后同样有可能提高视力。然而,在玻璃体切除术前视力为盲的一小部分原住民患者中,手术改善的可能性明显降低。需要进一步探讨该组不良结局相关的潜在因素。